Calton & Associates’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.76M Buy
28,488
+201
+0.7% +$57.5K 1.11% 21
2025
Q4
$8.14M Buy
28,287
+619
+2% +$173K 1.2% 17
2025
Q3
$7.18M Buy
27,668
+6,636
+32% +$1.66M 1.08% 20
2025
Q2
$5.22M Buy
21,032
+616
+3% +$152K 0.9% 24
2025
Q1
$5.4M Buy
20,416
+509
+3% +$136K 1.23% 17
2024
Q4
$5.05M Buy
19,907
+8,420
+73% +$2.27M 2.23% 9
2024
Q3
$3.24M Sell
11,487
-6,276
-35% -$1.74M 1.24% 16
2024
Q2
$4.72M Buy
17,763
+123
+0.7% +$32.2K 2.37% 9
2024
Q1
$4.77M Buy
17,640
+430
+2% +$113K 2.33% 9
2023
Q4
$4.31M Buy
+17,210
New +$4.08M 1.74% 11
2023
Q3
Sell
-17,325
Closed -$4.24M 252
2023
Q2
$4.24M Sell
17,325
-383
-2% -$93.2K 1.98% 10
2023
Q1
$4.22M Buy
17,708
+146
+0.8% +$35.1K 1.96% 10
2022
Q4
$4.36M Buy
17,562
+3,861
+28% +$936K 1.69% 9
2022
Q3
$3.06M Sell
13,701
-404
-3% -$96.4K 1.76% 12
2022
Q2
$3.32M Buy
14,105
+718
+5% +$173K 1.85% 10
2022
Q1
$3.4M Sell
13,387
-52
-0.4% -$12.8K 1.01% 18
2021
Q4
$3.58M Buy
13,439
+767
+6% +$196K 0.96% 20
2021
Q3
$3.13M Buy
12,672
+120
+1% +$30.8K 0.69% 30
2021
Q2
$3.1M Buy
12,552
+1,264
+11% +$302K 0.59% 36
2021
Q1
$2.58M Buy
11,288
+542
+5% +$124K 0.5% 39
2020
Q4
$2.4M Buy
10,746
+799
+8% +$171K 0.43% 46
2020
Q3
$2.03M Buy
9,947
+37
+0.4% +$7.49K 0.42% 49
2020
Q2
$1.91M Sell
9,910
-4,494
-31% -$843K 0.42% 50
2020
Q1
$2.39M Buy
14,404
+585
+4% +$107K 0.59% 38
2019
Q4
$2.65M Buy
13,819
+2,144
+18% +$384K 0.53% 35
2019
Q3
$1.96M Buy
11,675
+1,037
+10% +$177K 0.43% 46
2019
Q2
$1.85M Sell
10,638
-945
-8% -$160K 0.52% 33
2019
Q1
$2M Sell
11,583
-89
-0.8% -$15.1K 0.61% 27
2018
Q4
$1.88M Buy
11,672
+1,810
+18% +$307K 0.69% 22
2018
Q3
$1.78M Buy
9,862
+925
+10% +$159K 0.52% 30
2018
Q2
$1.53M Buy
8,937
+2,694
+43% +$424K 0.44% 34
2018
Q1
$959K Buy
6,243
+3,351
+116% +$535K 0.28% 77
2017
Q4
$479K Buy
+2,892
New +$444K 0.12% 169

Other funds holding VHT

Calton & Associates's VHT Position: Q1 2026 in Review

Calton & Associates increased its Vanguard Health Care ETF (VHT) stake by 0.71% in Q1 2026, buying an estimated $57.5K and bringing the position to 28,488 shares worth $7.76M. The position accounts for 1.11% of the portfolio, ranked #21.

Calton & Associates first reported a position in VHT in Q4 2017 and has held it in 33 quarters since. The position peaked at $8.14M in Q4 2025. 1,085 funds tracked by Wall St. Rank hold VHT as of Q1 2026.

  • Calton & Associates held 28,488 shares of Vanguard Health Care ETF worth $7.76M as of Q1 2026.
  • Calton & Associates bought 201 Vanguard Health Care ETF shares in Q1 2026, an estimated $57.5K.
  • Vanguard Health Care ETF made up 1.11% of Calton & Associates's portfolio in Q1 2026, its #21 holding.
  • Calton & Associates first reported a position in Vanguard Health Care ETF in Q4 2017 and has held it in 33 quarters since.
  • Calton & Associates's Vanguard Health Care ETF position peaked at $8.14M in Q4 2025.
  • 1,085 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q1 2026.

Based on Calton & Associates's 13F filing for Q1 2026, filed 13 May 2026.